TCM Limited (BOM:524156)
India · Delayed Price · Currency is INR 49.09
-1.57 (-3.10%)
At close: May 27, 2026
TCM Limited Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Revenue | 197.38 | 260.06 | 322.32 | 73.48 | 35.55 |
Other Revenue | 9.62 | - | - | - | - |
| 207 | 260.06 | 322.32 | 73.48 | 35.55 | |
Revenue Growth (YoY) | -20.40% | -19.32% | 338.67% | 106.71% | -16.36% |
Cost of Revenue | 142.86 | 188.75 | 235.34 | 60.1 | 27.6 |
Gross Profit | 64.14 | 71.31 | 86.98 | 13.38 | 7.95 |
Selling, General & Admin | 48.69 | 49.1 | 60.13 | 22.11 | 22.49 |
Other Operating Expenses | 50.89 | 42.03 | 49.28 | 28.04 | 25.54 |
Operating Expenses | 105.15 | 94.64 | 112.37 | 53.87 | 49.76 |
Operating Income | -41.01 | -23.32 | -25.39 | -40.49 | -41.81 |
Interest Expense | -19.24 | -5.91 | -1.42 | -2.68 | -0.08 |
Interest & Investment Income | - | 1.31 | 1.15 | 0.15 | - |
Other Non Operating Income (Expenses) | - | 1.09 | 0 | 0.07 | 0.12 |
EBT Excluding Unusual Items | -60.25 | -26.83 | -25.66 | -42.95 | -41.77 |
Gain (Loss) on Sale of Assets | - | -1.81 | - | - | 3.68 |
Other Unusual Items | - | 42.3 | 3.16 | - | -20.72 |
Pretax Income | -60.25 | 13.65 | -22.5 | -42.95 | -58.81 |
Income Tax Expense | -0.38 | -0.34 | 0.4 | -0.24 | -0.02 |
Earnings From Continuing Operations | -59.87 | 13.99 | -22.89 | -42.72 | -58.79 |
Minority Interest in Earnings | 1.76 | 2.13 | 3.39 | 2.67 | 7.42 |
Net Income | -58.11 | 16.12 | -19.5 | -40.04 | -51.37 |
Net Income to Common | -58.11 | 16.12 | -19.5 | -40.04 | -51.37 |
Shares Outstanding (Basic) | 7 | 7 | 7 | 7 | 3 |
Shares Outstanding (Diluted) | 7 | 7 | 7 | 7 | 3 |
Shares Change (YoY) | 0.01% | - | 11.49% | 97.33% | - |
EPS (Basic) | -7.77 | 2.16 | -2.61 | -5.97 | -15.11 |
EPS (Diluted) | -7.77 | 2.16 | -2.61 | -5.97 | -15.11 |
Free Cash Flow | -59.94 | -106.01 | 13.58 | -130.62 | -43.62 |
Free Cash Flow Per Share | -8.02 | -14.18 | 1.82 | -19.47 | -12.83 |
Gross Margin | 30.99% | 27.42% | 26.99% | 18.21% | 22.36% |
Operating Margin | -19.81% | -8.97% | -7.88% | -55.11% | -117.62% |
Profit Margin | -28.07% | 6.20% | -6.05% | -54.50% | -144.52% |
Free Cash Flow Margin | -28.96% | -40.76% | 4.21% | -177.78% | -122.72% |
EBITDA | -35.43 | -19.93 | -22.77 | -37.07 | -40.34 |
EBITDA Margin | -17.12% | -7.66% | -7.06% | -50.45% | -113.48% |
D&A For EBITDA | 5.58 | 3.39 | 2.62 | 3.42 | 1.47 |
EBIT | -41.01 | -23.32 | -25.39 | -40.49 | -41.81 |
EBIT Margin | -19.81% | -8.97% | -7.88% | -55.11% | -117.62% |
Revenue as Reported | 207 | 304.75 | 326.63 | 73.69 | 44.4 |
Advertising Expenses | - | 0.88 | 1.6 | 0.76 | 0.4 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.